• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

ASCO Audio Journal of Oncology in Advance – July 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007

0
  • by alexperjescuadmin
  • in AJO · ASCO · Oncology
  • — 15 Jul, 2007
Volker Diehl
Volker Diehl
George Canellos
George Canellos

Hodgkin’s Disease: 10-Year Results Show Further Benefit From Escalated BEACOPP Therapy

REFERENCE: Abstract 8015, ASCO Annual Meeting Chicago June 1-5, 2007
VOLKER DIEHL, University of Cologne
GEORGE CANELLOS, Dana-Farber Cancer Institute, Boston

Long-term results presented at the ASCO Annual Meeting have given further support to the use of an escalated BEACOPP regimen in patients with Hodgkin’s disease. Volker Diehl, of the University of Cologne, discussed his latest data with George Canellos, of the Dana-Farber Cancer Institute in Boston, and Peter Goodwin.

Sandra Horning
Sandra Horning

Less Radiation Is Significantly Better for Patients With Favorable Hodgkin’s Disease

REFERENCE: Abstract 8014, ASCO Annual Meeting Chicago June 1-5, 2007
SANDRA HORNING, Stanford University
Less aggressive radiotherapy when combined with chemotherapy has proven superior to the use of extended field radiotherapy for patients with favorable prognosis Hodgkin’s disease. This finding from long-term follow-up of mature data from a Stanford University study was presented at the 2007 ASCO Annual Meeting in Chicago. After her talk in the lymphoma session, Sandra Horning talked with Sarah Maxwell about her group’s latest results.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
Share

Tags: annual meetingASCOaudio journal of oncologygeorge canellosOncologysandra horningvolker diehl

You may also like...

  • ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando 3 Feb, 2007
  • Dana Tsui Blood test for free tumour DNA could guide breast cancer therapy 3 Apr, 2013
  • Oropharyngeal Carcinoma: Better Outlook From Human Papilloma Virus-Directed Therapies— Different Patient Characteristics, New Therapeutic Opportunities Oropharyngeal Carcinoma: Better Outlook From Human Papilloma Virus-Directed Therapies— Different Patient Characteristics, New Therapeutic Opportunities 15 Apr, 2009
  • PD-L1 Checkpoint Inhibitor Immunotherapy Boosts Survival in Lung Cancer PD-L1 Checkpoint Inhibitor Immunotherapy Boosts Survival in Lung Cancer 6 Dec, 2016

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Medicine: Intensive Care: Prophylactic Steroids Prevent Postextubation Laryngeal Oedema
  • Next story Rosiglitazone for Patients with Diabetes: Cardiovascular Outcomes Trial Findings
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • New Front Line Standard for Older Patients with…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT…
    • Microbiome Diversity Key To Survival After…
  • Home
  • Oncology
  • AJO
  • ASCO Audio Journal of Oncology in Advance – July 15th, 2007 – reporting from: ASCO Annual Meeting, Chicago, June 1-5, 2007

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.